Literature DB >> 18467718

Utilization and outcomes of minimally invasive radical prostatectomy.

Jim C Hu1, Qin Wang, Chris L Pashos, Stuart R Lipsitz, Nancy L Keating.   

Abstract

PURPOSE: Demand for minimally invasive radical prostatectomy (MIRP) to treat prostate cancer is increasing; however, outcomes remain unclear. We assessed utilization, complications, lengths of stay, and salvage therapy rates for MIRP versus open radical prostatectomy assessed whether MIRP surgeon volume is associated with better outcomes.
METHODS: We identified 2,702 men undergoing MIRP and open radical prostatectomy during 2003 to 2005 from a national 5% sample of Medicare beneficiaries. We assessed the association between surgical approach and outcomes, adjusting for surgeon volume, age, race, comorbidity, and geographic region.
RESULTS: MIRP utilization increased from 12.2% in 2003 to 31.4% in 2005. Men undergoing MIRP versus open radical prostatectomy had fewer perioperative complications (29.8% v 36.4%; P = .002) and shorter lengths of stay (1.4 v 4.4 days; P < .001); however, they were more likely to receive salvage therapy (27.8% v 9.1%, P < .001). In adjusted analyses, MIRP versus open radical prostatectomy was associated with fewer perioperative complications (odds ratio [OR], 0.73; 95% CI, 0.60 to 0.90), shorter lengths of stay (parameter estimate, -2.99; 95% CI, -3.45 to -2.53) but more anastomotic strictures (OR, 1.40; 95% CI, 1.04 to 1.87) and higher rates of salvage therapy (OR, 3.67; 95% CI, 2.81 to 4.81). Patients of high-volume MIRP experienced fewer anastomotic strictures (OR, 0.93; 95% CI, 0.87 to 0.99) and less salvage therapy (OR, 0.92; 95% CI, 0.88 to 0.98).
CONCLUSION: Men undergoing MIRP versus open radical prostatectomy have lower risk for perioperative complications and shorter lengths of stay, but are at higher risk for salvage therapy and anastomotic strictures. However, risk for these unfavorable outcomes decreases with increasing MIRP surgical volume.

Entities:  

Mesh:

Year:  2008        PMID: 18467718     DOI: 10.1200/JCO.2007.13.4528

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  56 in total

1.  The case for conventional laparoscopic sacrocolpopexy.

Authors:  Michael Heit
Journal:  Int Urogynecol J       Date:  2012-01-27       Impact factor: 2.894

2.  [Life without robots : What is left for the urologist?].

Authors:  O Hakenberg
Journal:  Urologe A       Date:  2010-08       Impact factor: 0.639

3.  Open versus minimally invasive radical prostatectomy.

Authors:  Stacy Loeb; Alan W Partin
Journal:  Rev Urol       Date:  2010

Review 4.  Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes.

Authors:  Stephen B Williams; Jim C Hu
Journal:  World J Urol       Date:  2010-11-21       Impact factor: 4.226

5.  [Diagnostics and therapy of localized prostate cancer: a problem-oriented account].

Authors:  C Weber
Journal:  Radiologe       Date:  2011-11       Impact factor: 0.635

6.  Learning curve assessment of robot-assisted radical prostatectomy compared with open-surgery controls from the premier perspective database.

Authors:  John W Davis; Usha S Kreaden; Jessica Gabbert; Raju Thomas
Journal:  J Endourol       Date:  2014-02-06       Impact factor: 2.942

7.  Matched comparison of robot-assisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients.

Authors:  Jonas Busch; Mark L Gonzalgo; Natalia Leva; Michelle Ferrari; Hannes Cash; Carsten Kempkensteffen; Stefan Hinz; Kurt Miller; Ahmed Magheli
Journal:  World J Urol       Date:  2014-05-23       Impact factor: 4.226

8.  Robotic prostatectomy: The new standard of care or a marketing success?

Authors:  Eric P Estey
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

9.  The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy.

Authors:  Quoc-Dien Trinh; Maxine Sun; Simon P Kim; Jesse Sammon; Keith J Kowalczyk; Ariella A Friedman; Shyam Sukumar; Praful Ravi; Fred Muhletaler; Piyush K Agarwal; Shahrokh F Shariat; Jim C Hu; Mani Menon; Pierre I Karakiewicz
Journal:  Urol Oncol       Date:  2013-03-01       Impact factor: 3.498

10.  Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.

Authors:  James B Yu; Pamela R Soulos; Jeph Herrin; Laura D Cramer; Arnold L Potosky; Kenneth B Roberts; Cary P Gross
Journal:  J Natl Cancer Inst       Date:  2012-12-14       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.